Work

Afatinib in the treatment of EGFR mutation-positive NSCLC – A network meta-analysis

Year: 2014

Type: review

Study designs: Systematic Review, Meta-Analysis

Source: Lung Cancer

DOI: 10.1016/j.lungcan.2014.05.007

Authors: Sanjay Popat, Tony Mok, James Chih-Hsin Yang, Yi-Long Wu, Juliane Lungershausen, Uz Stammberger, Ingolf Griebsch, Tiago Fonseca, Luis Paz-Ares

Institutions: Royal Marsden Hospital, Chinese University of Hong Kong, National Taiwan University, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Boehringer Ingelheim (Germany), IQVIA (United States), Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Boehringer Ingelheim, Medical Research Council

OpenAlex ID: W2137046878

FWCI: 1.596

Cites: 49

Cited by: 48

Related to: 10